We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Olympus America Acquires Bacus Labs

By Labmedica staff writers
Posted on 27 Jul 2006
Olympus America Inc. More...
(Melville, NY, USA), a precision technology company that designs imaging systems for use in healthcare and life sciences, has acquired privately-owned Bacus Laboratories, Inc. (BLI, Lombard, IL, USA). BLI will retain its name, and all employees will retain their positions. Licenses and other business relationships will remain mostly unaffected. Financial details were not disclosed.

By securing BLI's patents and capabilities as part of the transaction, Olympus has gained access to two key technologies, virtual microscope slide and telemedicine, enabling the company to offer a one-step solution to companies seeking a virtual microscope slide system. Virtual slides allow professionals to review biopsies and other pathology images without handling traditional glass slides. Using telemedicine, doctors can share highly detailed microscope slide images over the internet for long-distance consultation.

Among the products to be sold by the combined company is the Bliss system, designed for a single workstation, which is a combination of an Olympus microscope with BLI software. BLI also provides virtual microscope slides and internet software for medical education.

More than 60% of professional decisions made by physicians are influenced by medical testing. Medical slides contain so much high-resolution data that it can take thousands of typical digital pictures to reproduce all the data in one image, and require powerful computers to store the data. The combination of Olympus and BLI technologies can help streamline the process, save substantial expense, and enhance patient care.

Dr, Stephen S. Tang, group vice president and general manager of Life Science, Olympus America, said "Being able to digitize slides and share analysis, and attach images to a patient's file is the step we have been waiting for. It paves the way to more informed decisions by physicians, better-served patients, and enhanced teaching and training.”





Related Links:
Olympus America
Bacus Laboratories

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.